Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
65.00    -0.40 (-0.61%)
Bid:
65.00
Ask:
65.50
Spread: 0.50 (0.769%)
Market Cap: £574.23m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Transaction in Own Shares

21 Feb 2025 07:00

RNS Number : 9302X
IP Group PLC
21 February 2025
Β 

Transaction in Own Shares

Β 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), today announces that Numis Securities Limited (which is trading for these purposes as Deutsche Numis) ("Deutsche Numis"), purchased on behalf of IP Group the number of ordinary shares of 2 pence each on the London Stock Exchange as set out in the table below (the Repurchased Shares) pursuant to the IP Group share buyback programme, an extension to which was announced on 09 January 2025 (the Buyback Programme).

Date of purchase:

20/02/2025

Number of ordinary shares purchased:

355,000

Highest price paid per ordinary share (GBp):

46.55

Lowest price paid per ordinary share (GBp):Β 

45.35

Volume weighted average price paid per ordinary share (GBp):Β 

45.8634

Β 

Any Ordinary Shares purchased under the Buyback Programme will be cancelled in order to decrease the number of Ordinary Shares in issue.Β Accordingly, following the above transaction and subsequent cancellation of the Repurchased Shares, the Group has 962,433,125 ordinary shares in issue with voting rights. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, IP Group under the FCA's Disclosure Guidance and Transparency Rules. There are no Ordinary Shares held in treasury.

Β 

IP Group will make further announcements following the completion of any additional purchases pursuant to the Buyback Programme.

Β 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Deutsche Numis on behalf of IP Group as part of the Buyback Programme.

Β 

Both aggregate data in respect of the Repurchased Shares as well as the individual purchases are set out below.

Β 

Aggregate information:

Β 

Issuer name and ISIN: IP Group plc (ISIN: GB00B128J450)

Β 

Date of purchases:

20/02/2025

Number of ordinary shares purchased:

355,000

Volume weighted average price (pence):

45.8634

Β 

Individual transactions:

Β 

Number of ordinary shares purchased

Transaction price(GBp share)

Time of transaction (UK Time)

Trading venue

8198

46.35

Β 08:41:01

XLON

662

46.35

Β 08:41:01

XLON

1

46.55

Β 08:56:10

XLON

698

46.55

Β 08:56:10

XLON

765

46.55

Β 08:56:10

XLON

8094

46.50

Β 09:08:32

XLON

1434

46.50

Β 09:21:51

XLON

8058

46.50

Β 09:21:51

XLON

8261

46.30

Β 09:50:18

XLON

4570

46.25

Β 09:58:48

XLON

4570

46.25

Β 09:58:48

XLON

500

46.35

Β 10:42:13

XLON

752

46.35

Β 10:42:13

XLON

721

46.35

Β 10:42:13

XLON

1068

46.15

Β 10:47:32

XLON

7536

46.15

Β 10:47:32

XLON

6284

46.15

Β 11:17:22

XLON

10000

46.25

Β 11:26:58

XLON

2563

46.15

Β 11:38:02

XLON

3267

46.15

Β 11:38:02

XLON

3267

46.15

Β 11:38:02

XLON

903

46.10

Β 11:59:22

XLON

5591

46.10

Β 11:59:22

XLON

3287

46.10

Β 11:59:22

XLON

8642

46.10

Β 12:27:00

XLON

1143

46.00

Β 12:44:47

XLON

8752

46.00

Β 12:44:47

XLON

719

46.10

Β 13:00:08

XLON

789

46.10

Β 13:00:08

XLON

692

46.10

Β 13:03:30

XLON

664

46.10

Β 13:03:30

XLON

3800

46.10

Β 13:03:30

XLON

900

46.10

Β 13:03:30

XLON

2766

46.10

Β 13:03:30

XLON

1606

46.00

Β 13:04:02

XLON

10171

46.00

Β 13:04:02

XLON

7930

45.95

Β 13:35:04

XLON

8058

45.95

Β 13:37:04

XLON

8117

45.90

Β 13:42:51

XLON

1725

45.90

Β 13:45:35

XLON

2251

45.90

Β 13:47:03

XLON

8947

45.85

Β 13:47:55

XLON

8896

45.80

Β 14:02:30

XLON

8996

45.70

Β 14:13:14

XLON

220

45.70

Β 14:13:14

XLON

83

45.70

Β 14:13:14

XLON

2262

45.60

Β 14:29:41

XLON

2336

45.80

Β 14:36:23

XLON

2251

45.80

Β 14:45:13

XLON

8473

45.80

Β 14:45:13

XLON

416

45.80

Β 14:45:13

XLON

7964

45.80

Β 14:45:13

XLON

3255

45.80

Β 14:45:13

XLON

2136

45.70

Β 14:47:10

XLON

12752

45.70

Β 14:47:10

XLON

9495

45.60

Β 14:57:17

XLON

9174

45.55

Β 14:57:17

XLON

9688

45.50

Β 15:01:40

XLON

171

45.60

Β 15:26:33

XLON

3500

45.60

Β 15:26:33

XLON

4363

45.60

Β 15:26:33

XLON

863

45.60

Β 15:26:33

XLON

1718

45.60

Β 15:29:33

XLON

2015

45.60

Β 15:29:33

XLON

1900

45.60

Β 15:30:00

XLON

1588

45.60

Β 15:30:00

XLON

1732

45.60

Β 15:30:00

XLON

651

45.60

Β 15:30:00

XLON

726

45.60

Β 15:30:00

XLON

8642

45.50

Β 15:40:39

XLON

9381

45.50

Β 15:40:39

XLON

9023

45.35

Β 15:47:03

XLON

3500

45.40

Β 15:57:27

XLON

5319

45.40

Β 15:57:27

XLON

1147

45.35

Β 16:01:33

XLON

7893

45.35

Β 16:01:53

XLON

9085

45.70

Β 16:10:33

XLON

1523

45.70

Β 16:11:41

XLON

6843

45.70

Β 16:11:41

XLON

8700

45.70

Β 16:11:41

XLON

1191

45.70

Β 16:11:41

XLON

1444

45.55

Β 16:20:00

XLON

474

45.55

Β 16:20:00

XLON

431

45.55

Β 16:21:30

XLON

1588

45.60

Β 16:21:33

XLON

1235

45.60

Β 16:21:33

XLON

1235

45.60

Β 16:21:33

XLON

Β 

Β 

Β 

For more information, please contact:

Β 

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7967 312125

Portland

Alex Donaldson

+44 (0) 7516 729702

Β 

Further information on IP Group is available on our website: www.ipgroupplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
POSGZGZZNGDGKZM
Date   Source Headline
11th Jun 20267:00 amRNSHolding(s) in Company
3rd Jun 20267:00 amRNSHolding(s) in Company
2nd Jun 20267:00 amRNSHolding(s) in Company
29th May 20267:00 amRNSHolding(s) in Company
29th May 20267:00 amRNSHolding(s) in Company
28th May 20267:00 amRNSHolding(s) in Company
13th May 20265:30 pmRNSNotice of AGM
12th May 20269:10 amRNS-REnterprise reports positive results from P2 trial
11th May 20264:25 pmRNSHolding(s) in Company
11th May 20264:19 pmRNSHolding(s) in Company
7th May 20267:00 amRNSAppointment of Chair Designate
23rd Apr 202612:18 pmRNSDirector/PDMR Shareholding
21st Apr 20267:00 amRNS-RFirst Light announces £25m successful first close
15th Apr 20265:00 pmRNSAnnual Financial Report
14th Apr 20269:25 amRNSHolding(s) in Company
30th Mar 20262:00 pmRNSNew climate fund launch with Australia's CEFC
26th Mar 202610:00 amRNSHolding(s) in Company
25th Mar 20262:00 pmRNSHolding(s) in Company
19th Mar 20265:30 pmRNSHolding(s) in Company
17th Mar 20267:00 amRNSIP Group plc 2025 Annual Results Release
17th Mar 20267:00 amRNSIP Group plc 2025 Annual Results Release
13th Mar 20265:45 pmRNSHolding(s) in Company
12th Mar 202611:00 amRNSHolding(s) in Company
12th Mar 20269:00 amRNSNotice of Results
12th Mar 20269:00 amRNSNotice of Results
4th Mar 20267:00 amRNS-RPortfolio company Oxa raises $103m in Series D
26th Feb 20262:53 pmRNSHolding(s) in Company
26th Feb 20269:30 amRNSHolding(s) in Company
25th Feb 20265:51 pmRNSHolding(s) in Company
11th Feb 20269:01 amRNS-RMicrobiotica announces positive P1b trial results
30th Jan 20267:00 amRNSHolding(s) in Company
29th Jan 20267:00 amRNSHolding(s) in Company
20th Jan 202612:36 pmRNSHolding(s) in Company
14th Jan 20267:00 amRNSDirectorate change
14th Jan 20267:00 amRNSHolding(s) in Company
12th Jan 20266:25 pmRNSHolding(s) in Company
7th Jan 20262:06 pmRNSPulmocide announces termination of Phase 3 study
2nd Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 20267:00 amRNSHolding(s) in Company
18th Dec 20254:13 pmRNSHolding(s) in Company
18th Dec 20254:13 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNSHolding(s) in Company
5th Dec 20255:26 pmRNSHolding(s) in Company
4th Dec 20254:13 pmRNSHolding(s) in Company
1st Dec 20255:37 pmRNSTotal Voting Rights
20th Nov 20257:00 amRNSCompletion of share buyback programme
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20251:10 pmRNSArtios completes oversubscribed $115m financing
14th Nov 20255:47 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.